Private Wealth Management Group’s Maravai LifeSciences MRVI Stock Holding History

Private Wealth Management Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-174	Closed	-$949	–	1551
2024 Q4	$949	Hold	174	–	–	﹤0.01%	1314
2024 Q3	$1.45K	Hold	174	–	–	﹤0.01%	1182
2024 Q2	$1.25K	Hold	174	–	–	﹤0.01%	1214
2024 Q1	$1.51K	Hold	174	–	–	﹤0.01%	1098
2023 Q4	$1.14K	Buy	+174	New	+$1.12K	﹤0.01%	1216

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Wealth Management Group's MRVI Position: Q1 2025 in Review

Private Wealth Management Group sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 174 shares — an estimated $949 sold.

Private Wealth Management Group first reported a position in MRVI in Q4 2023 and held it in 5 quarters. The position peaked at $1.51K in Q1 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

Private Wealth Management Group reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
Private Wealth Management Group sold 174 Maravai LifeSciences shares in Q1 2025, an estimated $949.
Private Wealth Management Group first reported a position in Maravai LifeSciences in Q4 2023 and held it in 5 quarters.
Private Wealth Management Group's Maravai LifeSciences position peaked at $1.51K in Q1 2024.
184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Private Wealth Management Group's 13F filing for Q1 2025, filed 2 May 2025.